Lexicon Pharmaceuticals, Inc. (LXRX)
$1.68-4.55%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $746M
- Beta
- 1.08
- P/E (TTM)
- -11.64
- Short % float
- 12.05%
- Days to cover
- 6.2
- SI change
- -10.3%
- 1W
- -7.69%
- 1M
- -16.83%
- vs SPY 1W
- -8.85%
- vs SPY 1M
- -19.82%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on LXRX?
- LOPJLB’s latest quantitative signal on Lexicon Pharmaceuticals, Inc. (LXRX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is LXRX in?
- Lexicon Pharmaceuticals, Inc. (LXRX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Lexicon Pharmaceuticals, Inc. (LXRX) do?
- Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the end-to-end process of identifying, advancing, and bringing to market novel therapeutic compounds. Its development pipeline includes orally administered small molecule drug candidates such as Sotagliflozin, which has successfully concluded Phase III clinical studies for treating both heart failure and type 1 diabetes, …